IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10968188 B1

PDFFull Text
Date of Patent:
Apr. 06, 2021

Filed:

May. 14, 2020

Benzothiazol compounds and methods using the same for treating neurodegenerative disorders

Applicant:

1st Biotherapeutics, Inc., Gyeonggi-do, KR;

Inventors:

Jinhwa Lee, Gyeonggi-do, KR;

Suyeon Jo, Gyeonggi-do, KR;

A Yeong Park, Gyeonggi-do, KR;

Gwibin Lee, Gyeonggi-do, KR;

Jae Eun Kim, Seoul, KR;

Misoon Kim, Gyeonggi-do, KR;

Gyooseung Jung, Gyeonggi-do, KR;

Seung Mook Lim, Gyeonggi-do, KR;

Keonseung Lim, Gyeonggi-do, KR;

Minwoo Lee, Gyeonggi-do, KR;

Heekyoung Yang, Gyeonggi-do, KR;

Hyonam Kim, Gyeonggi-do, KR;

Hyeongjun Kim, Seoul, KR;

Wanjun Li, Hubei, CN;

Mingzhu Fan, Hubei, CN;

Assignee:

1st Biotherapeutics, Inc., Gyeongg-do, KR;

Attorney:

Harness, Dickey & Pierce, P.L.C.

Primary Examiner:

Brian E McDowell

Int. Cl.
CPC ...
A61K 31/428 (2006.01); C07D 277/82 (2006.01); A61P 25/28 (2006.01); A61P 25/16 (2006.01); C07D 513/04 (2006.01); C07D 471/04 (2006.01); A61K 31/506 (2006.01); A61K 31/4439 (2006.01); A61K 31/437 (2006.01); C07F 7/08 (2006.01); A61K 31/695 (2006.01); C07F 5/02 (2006.01); A61K 31/69 (2006.01); C07D 417/10 (2006.01); C07D 417/04 (2006.01);
U.S. Cl.
CPC ...
C07D 277/82 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/506 (2013.01); A61K 31/69 (2013.01); A61K 31/695 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); C07D 417/04 (2013.01); C07D 417/10 (2013.01); C07D 471/04 (2013.01); C07D 513/04 (2013.01); C07F 5/025 (2013.01); C07F 7/0812 (2013.01);
Abstract

The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.

Find Patent Forward Citations

Loading…